|
|
Toll free number : 1800 069 722 The APR collects information about pregnant women with epilepsy, treated and untreated, to determine which antiepileptic medications are safest for the baby while protecting the mother from seizures. The APR collects information before and after the delivery on the mother’s medical and family history, social and educational background, past pregnancies, and details about her epilepsy and its treatment. The APR also enrols pregnant women who are taking antiepileptic medications for conditions other than epilepsy, such as for control of pain and treatment of mood disorders. Participation by pregnant women with epilepsy is voluntary. The Australian Pregnancy Register (APR) is an independent research project, supported by the Epilepsy Society of Australia, Epilepsy Australia, Epilepsy Action, the Australian National Health and Medical Research Council, Sanofi–Aventis, Janssen-Cilag, Novartis, GSK, Pfizer and UCB Pharma. The APR is affiliated with a similar project of the International League Against Epilepsy. The research has been approved by the ethics committees of major hospitals. For further information, download the APR's information sheet [PDF 37KB]. Contact details
|
